Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2011-03-29
2011-03-29
Fay, Zohreh A (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S912000, C424S669000
Reexamination Certificate
active
07915312
ABSTRACT:
The present invention is directed to a physiological method for improving vision in a human patient. This method involves topical application to the eye, an amount of acetylcholine esterase inhibitor containing composition so that it is sufficient to provide a therapeutic benefit to improve the visual acuity in the human patient. The composition is administered topically and at bedtime after an eye straining work for about 20 minutes. The method disclosed herein is used for treatment and prevention of congenital and acquired color vision blindness, treatment of ocular hypertension and glaucoma, prevention of the progression of myopia, treatment of strabismus or squint, potentiation of best visual acuity, neuro-protection, treatment of aberrations secondary to pupil dilation.
REFERENCES:
patent: 3681495 (1972-08-01), Hussain
patent: 4490379 (1984-12-01), Podos
patent: 4977176 (1990-12-01), Amstutz et al.
patent: 5288735 (1994-02-01), Trager et al.
patent: 5704369 (1998-01-01), Scinto et al.
patent: 5778893 (1998-07-01), Potter
patent: 6273092 (2001-08-01), Nolan
patent: 6313155 (2001-11-01), Sponsel
patent: 2002/0035264 (2002-03-01), Kararli et al.
patent: 2002/0107238 (2002-08-01), Bandyopadhyay et al.
patent: WO 00/64425 (2000-11-01), None
patent: WO 02/24059 (2002-03-01), None
Adams, Chromatic and Luminosity Processing in Retinal Disease, American Journal of Optometry & Physiological Optics; Dec. 1982; vol. 59 (12): 954-960.
Bowman, The Clinical Assessment of Colour Discrimination in Senile Macular Degeneration, Acta Ophthalmologica, 1980 vol. 58 (3) : 337-346.
Bowman, The Relationship Between Color Discrimination and Visual Acuity in Senile Macular Degeneration, American Journal of Optometry , Mar. 1980; vol. 57 (3): 145-148.
Bresnick et al., Autosomal Dominantly Inherited Macular Dystrophy with Preferential Short-Wavelength Sensitive Cone Involvement, American Journal of Ophthalmology, Sep. 15, 1989; 108: 265-276.
Cheng et al., Visual Losses in Early Age-Related Maculopathy, Optometry and Vision Science, Feb. 1993; vol. 70 (2) : 89-96.
Chu, et. al., Clinical Studies of Color Vision with Gunkel's Chromagraph, Arch Ophthalmol Aug. 1983; vol. 101: 1232-1235.
Fishman, et. al., Color Vision Defects in Retinitis Pigmentosa, Annals of Ophthalmology, May 1981; 13 (5) : 609-618.
Zrenner, et. al., Cone Function and Cone Interaction in Hereditary Degenerations of the Central Retina, Documents Ophthalmologica, Jan. 31, 1986; vol. 62 (1) : 5-12.
Holz, et. al., Colour Contrast Sensitivity in Patients with Age-Related Bruch's Membrane Changes, German J. Ophthalmol Nov. 1995; vol. 4 : 336-341.
Kellner, et. al.; Hereditary Macular Dystrophies, Ophthalmologe 1998, Sep. 1995; vol. 9: 597-601 (Summary in English).
Mantyjarvi et al., Color Vision in Stargardt's Disease, International Ophthalmology Nov. 1992; 16 (6): 423-428.
Minato, Color Vision Defects of Macular Diseases; Nippon Ganka Gakkai Zasshi; ACTA Soc. Ophthalmol Japan; Apr. 1991; vol. 95: 354-362 (Abstract in English).
Smith, et. al., Color Matching and the Stiles-Crawford Effect in Observers with Early Age-Related Macular Changes, J Opt Soc Am A Dec. 1988; vol. 5 (12) : 2113-2121.
Swanson, et. al., Color Matches in Diseased Eyes with Good Acuity: Detection of Deficits in Cone Optical Density and in Chromatic Discrimination, J Opt Soc Am A Oct. 1995; vol. 12 (10); 2230-2236.
Cohen, Management of Errors of Refraction with Echothiophate Iodide, Surgery For Ectropion Aug. 1996; vol. 62 (2); 303-312.
Database Medline Online US National Library of Medicine (NLM), Bethesda, MD, US; Feb. 1961, Plamondon M: “Spectacular Treatment of Thrombosis of the Central Vein of the Retina with an Echothiophate Collyrium (phospholine iodide).” XP002351188, Database Accession No. NLM13736196; Relevant to Claims: 1,4,5,7,13-15.
& Laval Medical Feb. 1961; vol. 31; Feb. 1961 pp. 178-182; ISSN.: 0023-9046; Relevant to Claims 1-15 (abstract).
Database Biosis Online Biosciences Information Service, Philadelphia, PA, US; 1974; Vukcevich W M et al.: “Echothiophate and Flat Anterior Chambers” XP002351189; Database Accession No. PREV197764064667 (abstract) & Annals of Ophthalmology, vol. 6, No. 8, 1974, pp. 829-831, ISSN: 0003-4886; Relevant to Claim 1.
Lam T T et al.: “Clearance of S-(3-amino-2-hydroxypropyl) Phosphorothioate (WR-77913) in Rats” Experimental Eye Research, 1991, United Kingdom, vol. 52, No. 6, 1991, pp. 661-667, XP002351185, ISSN.: 0014-4835 (abstract) Relevant to Claims: 1-15.
Plamondon, “Spectacular Treatment of the Thrombosis of the Central Retina Vein by Means of an Echothiophate Collyrium (Phospholine Iodide)”, Laval Medical, vol. 31, No. 2, Feb. 1961, pp. 178-181. w/English language translation).
Vukcevich, M.D., et al., “Echothiophate and Flat Anterior Chambers”, Annals of Ophthalmology, Aug. 1974, pp. 829-831.
Zegarra, M.D., et al., “Partial Occlusion of the Central Retinal Vein”, American Journal of Ophthalmology, vol. 96, No. 3, Sep. 1983, pp. 330-337.
Physicians' Desk Reference, 29 edition, 2001, pp. 321-323.
Cohen, S.W., “Management of Errors of Refraction with Echothiophate Iodide. A Preliminary Report”American Journal of Opthalmology, Opthalmic. Publ., Chicago, IL., vol. 62, No. 2, Aug. 1966 pp. 303-312, XP009060321.
Database Medline [online] U.S. National Library of Medicine (NLM), Bethesda, MD.; Sep. 1983; Hiatt, R.L., “Medical Management of Accomodative Esotropia”Journal of Pediatric Opthalmology and Strabismus, Sep.-Oct. 1983, vol. 20., No. 5, Sep. 1983 pp. 199-201, XP002471257.
Erikson-Lamy, K.A. et al., “Cholinergic Drugs Alter Ciliary Muscle Response and Receptor Content,”Investigative Opthalmology and Visual Science, Feb. 1987, vol. 28, No. 2, pp. 375-383, XP002471256.
Mills, at al., “Perianesthesia Care of Adults and Pediatric Strabismus Surgery Patients,”Journal of Perianesthesia Nursing, Saunders, W.B., vol. 13, No. 1, Feb. 1998, pp. 16-25, XP005266234.
Parks, M. M., Management of Acquired EsotropiaThe British Journal of Opthalmology, Mar. 1974, vol. 58, No. 3, pp. 240-247, XP 002471255.
Fay Zohreh A
Kumar Nanda P. B.
Reed Smith LLP
LandOfFree
Physiological method of improving vision does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Physiological method of improving vision, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Physiological method of improving vision will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2650907